APATINIB
APATINIB Uses, Dosage, Side Effects, Food Interaction and all others data.
APATINIB is under investigation in clinical trial NCT02726854 (Apatinib as Second-line Treatment of Advanced Pancreatic Cancer).
Trade Name | APATINIB |
Generic | Rivoceranib |
Rivoceranib Other Names | APATINIB, Rivoceranib |
Type | |
Formula | C24H23N5O |
Weight | Average: 397.482 Monoisotopic: 397.190260381 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here APATINIB